The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict CR Bard's revenues will expand 2.4% and EPS will grow 1.2%.
The average estimate for revenue is $736.6 million. On the bottom line, the average EPS estimate is $1.64.
Last quarter, CR Bard reported revenue of $742.6 million. GAAP reported sales were 2.4% higher than the prior-year quarter's $725.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.62. GAAP EPS were $1.54 for Q2 versus -$0.55 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 61.5%, 50 basis points worse than the prior-year quarter. Operating margin was 27.1%, 130 basis points worse than the prior-year quarter. Net margin was 18.0%, 2,460 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $2.99 billion. The average EPS estimate is $6.63.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 255 members out of 264 rating the stock outperform, and nine members rating it underperform. Among 92 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 91 give CR Bard a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CR Bard is hold, with an average price target of $101.53.
- Add CR Bard to My Watchlist.